Tokyo, Jan. 22 (Jiji Press)–Takeda Pharmaceutical Co. has started a clinical test in Japan for U.S. biopharmaceutical firm Moderna Inc.’s coronavirus vaccine.
   The phase 1-2 study is joined by 200 adults, the Japanese drug maker said Thursday.


Similar articles:

Leave a Reply

Your email address will not be published. Required fields are marked *